Cargando…

SEVERE REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN ONCOLOGY PATIENT WITH COVID-19: RARE BUT FATAL!

Detalles Bibliográficos
Autores principales:	DULU, ALINA, PASTORES, STEPHEN, SILVEY, KATHERINE, TAYBAN, KATE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Critical Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503143/ http://dx.doi.org/10.1016/j.chest.2021.07.644

Ejemplares similares

A VERY PROLONGED AND ULTIMATELY FATAL COURSE OF COVID-19 IN A PATIENT WITH LYMPHOMA
por: DULU, ALINA, et al.
Publicado: (2021)

CHARACTERISTICS AND ICU OUTCOMES OF PATIENTS WITH CANCER WITH ACUTE RESPIRATORY FAILURE DUE TO COVID-19
por: Dang, Michael, et al.
Publicado: (2020)

IMMUNE THROMBOCYTOPENIA SECONDARY TO COVID-19
por: AGRAWAL, AVNI, et al.
Publicado: (2021)

A MATTER OF PERCEPTION: IMPACT OF COVID-19 PANDEMIC ON TRAINEE PROCEDURAL COMPETENCY IN THE ICU
por: HOSSAIN, SAAMIA, et al.
Publicado: (2021)

IMMUNE THROMBOCYTOPENIA WITH COVID-19 VACCINATION: A CASE REPORT
por: SAMPRATHI, A.
Publicado: (2022)

ACUTE MESENTERIC ISCHEMIA: A RARE BUT FATAL COMPLICATION IN COVID-19
por: NANGRANI, KUNAL, et al.
Publicado: (2021)

FATAL INTRACEREBRAL HEMORRHAGE IN A PATIENT WITH SEVERE COVID-19 INFECTION
por: Sanchez Fernandez, Lady, et al.
Publicado: (2020)

COVID-19-ASSOCIATED THROMBOTIC THROMBOCYTOPENIA PURPURA (TTP)
por: JAIN, HANISH, et al.
Publicado: (2022)

A FATAL EXTRAPULMONARY MANIFESTATION OF COVID-19
por: Para, Kiran, et al.
Publicado: (2020)

DIFFUSE ALVEOLAR HEMORRHAGE SECONDARY TO IMMUNE THROMBOCYTOPENIA FOLLOWING SARS-COV-2 VACCINATION: A CASE REPORT
por: CHENG, TIEWEI, et al.
Publicado: (2022)

COVID-19-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA: A FATAL NIGHTMARE
por: ABU-JUBARA, MUSA, et al.
Publicado: (2021)

VACCINE-INDUCED THROMBOCYTOPENIA AND THROMBOSIS: SAILING CLOSE TO THE WIND IN A PANDEMIC
por: SREEKANTAN NAIR, ARCHANA, et al.
Publicado: (2022)

FATAL CASE OF ACUTE CVA IN A YOUNG PATIENT DUE TO COVID-19
por: Nadella, Swetha, et al.
Publicado: (2020)

REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA DUE TO COVID-19
por: CABRERA, RUBEN, et al.
Publicado: (2021)

COVID-19-ASSOCIATED LEUKOENCEPHALOPATHY PRESENTING AS NEW ONSET REFRACTORY STATUS EPILEPTICUS
por: MARSHALL, TANYA, et al.
Publicado: (2021)

A CASE OF IVIG REFRACTORY GUILLAIN-BARRÉ SYNDROME IN THE SETTING OF SUBCLINICAL COVID-19 INFECTION
por: DELEVEAUX, SPENCER, et al.
Publicado: (2021)

SEVERE HYPONATREMIA AS A MANIFESTATION OF A NEUROLOGIC DISORDER ASSOCIATED WITH THE COVID-19 VACCINE
por: MENCHACA, KRISTINA, et al.
Publicado: (2022)

First Report of Survival in Refractory Ventricular Fibrillation After Dual-Axis Defibrillation and Esmolol Administration
por: Boehm, Kevin M., et al.
Publicado: (2016)

REACTIVATION TB WITH SEVERE COVID-19
por: Garg, Natasha, et al.
Publicado: (2020)

A RARE PRESENTATION OF COVID-19-ASSOCIATED CENTRAL VENOUS THROMBOSIS
por: WU, BENITA, et al.
Publicado: (2022)

SARS-COV-2-RELATED PNEUMOMEDIASTINUM: A RARE PRESENTATION OF AN EQUALLY RARE COMPLICATION
por: RADOW, MARK, et al.
Publicado: (2021)

COVID-19, COMORBIDITIES, AND OUTCOMES IN SEVERE ILLNESS
por: HOOSHMAND, KEVIN, et al.
Publicado: (2021)

COVID-19 AND COXSACKIE B COINFECTION: A RARE CASE OF ACUTE PERICARDITIS
por: ENG, AMANDA, et al.
Publicado: (2021)

Respone to: “Limitations of Retrospective Chart Reviews to Determine Rare Events, and the Unknown Relative Risk of Droperidol”
por: Cole, Jon B., et al.
Publicado: (2021)

CORTICOSTEROID TREATMENT IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA
por: Hong, Gloria, et al.
Publicado: (2020)

SEVERE ACUTE KIDNEY INJURY IN COVID-19: NOT IRRECOVERABLE
por: Gayle, Latoya, et al.
Publicado: (2020)

Comparing Drugs for Out-of-hospital, Shock-refractory Cardiac Arrest: Systematic Review and Network Meta-analysis of Randomized Controlled Trials
por: Srisurapanont, Karan, et al.
Publicado: (2021)

MULTISYSTEM INFLAMMATORY SYNDROME OF ADULTS: A RARE COMPLICATION AFTER COVID-19 INFECTION
por: PARENT, JOHN, et al.
Publicado: (2022)

EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) VS CONVENTIONAL MECHANICAL VENTILATION FOR SEVERE ACUTE RESPIRATORY FAILURE DUE TO COVID-19: A MULTICENTER MATCHED COHORT STUDY
por: WHITMORE, SAGE, et al.
Publicado: (2022)

TOCILIZUMAB USE IN SEVERE COVID-19: A SINGLE CENTER EXPERIENCE
por: Poon, Joseph, et al.
Publicado: (2020)

SEVERE COVID-19 COMPLICATED WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A CASE REPORT
por: BRENNAN, CHRISTINE, et al.
Publicado: (2022)

CLINICAL OUTCOMES IN DIABETIC VS NON-DIABETIC PATIENTS WITH SEVERE COVID-19
por: Poon, Joseph, et al.
Publicado: (2020)

BEDSIDE CLINICAL CHANGES DURING LUNG RECRUITMENT IN PATIENTS WITH SEVERE COVID-19
por: AQUINO, R., et al.
Publicado: (2022)

HSV-2 ENCEPHALITIS TRIGGERED BY COVID-19-ASSOCIATED IMMUNE EXHAUSTION
por: COLETTI, ERIN, et al.
Publicado: (2021)

RECURRENT ISCHEMIC STROKES IN A PATIENT WITH SEVERE COVID-19 INFECTION AND PHOSPHATIDYLSERINE ANTIBODIES
por: Iguina, Michele, et al.
Publicado: (2020)

HYPONATREMIA SECONDARY TO VASOPRESSIN IN AN ECMO DEPENDENT PATIENT WITH SEVERE ARDS DUE TO COVID-19
por: HAFEEZ, ZEESHAN, et al.
Publicado: (2021)

DOES EXTRACORPOREAL MEMBRANE OXYGENATION SAVE LIVES IN COVID-19-ASSOCIATED SEVERE ARDS
por: VARGHESE, JOBIN, et al.
Publicado: (2021)

PNEUMOTHORAX IN SEVERELY ILL PATIENTS WITH COVID-19: SINGLE-CENTER RETROSPECTIVE CASE SERIES
por: SHAH, ROSHAN, et al.
Publicado: (2021)

Evaluation of medication changes following severe COVID-19 infection: a multicentre evaluation
por: MacTavish, Pamela, et al.
Publicado: (2021)

PNEUMOPERITONEUM IN SARS-COV-2: A RARE AND OMINOUS CLINICAL SIGN
por: PATEL, SANKALP, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vjqaku5i9hbqm2mb7d9llpd63k